These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25683592)

  • 1. A randomized controlled trial to compare the safety and effectiveness of doxycycline (200 mg daily) with oral prednisolone (0.5 mg kg(-1) daily) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial.
    Chalmers JR; Wojnarowska F; Kirtschig G; Nunn AJ; Bratton DJ; Mason J; Foster KA; Whitham D; Williams HC;
    Br J Dermatol; 2015 Jul; 173(1):227-34. PubMed ID: 25683592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.
    Chalmers JR; Wojnarowska F; Kirtschig G; Mason J; Childs M; Whitham D; Harman K; Chapman A; Walton S; Schmidt E; Godec TR; Nunn AJ; Williams HC
    Health Technol Assess; 2017 Mar; 21(10):1-90. PubMed ID: 28406394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial.
    Williams HC; Wojnarowska F; Kirtschig G; Mason J; Godec TR; Schmidt E; Chalmers JR; Childs M; Walton S; Harman K; Chapman A; Whitham D; Nunn AJ;
    Lancet; 2017 Apr; 389(10079):1630-1638. PubMed ID: 28279484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxycycline compared with prednisolone therapy for patients with bullous pemphigoid: cost-effectiveness analysis of the BLISTER trial.
    Mason JM; Chalmers JR; Godec T; Nunn AJ; Kirtschig G; Wojnarowska F; Childs M; Whitham D; Schmidt E; Harman K; Walton S; Chapman A; Williams HC;
    Br J Dermatol; 2018 Feb; 178(2):415-423. PubMed ID: 28940316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxycycline in the treatment of bullous pemphigoid: as good as systemic corticosteroids?
    Hofmann SC
    Br J Dermatol; 2015 Jul; 173(1):17-8. PubMed ID: 26174646
    [No Abstract]   [Full Text] [Related]  

  • 6. DOMINO, doxycycline 40 mg vs. minocycline 100 mg in the treatment of rosacea: a randomized, single-blinded, noninferiority trial, comparing efficacy and safety.
    van der Linden MMD; van Ratingen AR; van Rappard DC; Nieuwenburg SA; Spuls PI
    Br J Dermatol; 2017 Jun; 176(6):1465-1474. PubMed ID: 27797396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions for bullous pemphigoid.
    Khumalo N; Kirtschig G; Middleton P; Hollis S; Wojnarowska F; Murrell D
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002292. PubMed ID: 16034874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interventions for bullous pemphigoid.
    Khumalo N; Kirtschig G; Middleton P; Hollis S; Wojnarowska F; Murrell D
    Cochrane Database Syst Rev; 2003; (3):CD002292. PubMed ID: 12917929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of bullous pemphigoid following radiation therapy combined with nivolumab for renal cell carcinoma: A case report of abscopal toxicities.
    Huynh LM; Bonebrake BT; DiMaio DJ; Baine MJ; Teply BA
    Medicine (Baltimore); 2021 Dec; 100(49):e28199. PubMed ID: 34889301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT.
    Murrell DF; Joly P; Werth VP; Ujiie H; Worm M; Mangold AR; Avetisova E; Maloney J; Laws E; Mortensen E; Dubost-Brama A; Shabbir A
    Adv Ther; 2024 Jul; 41(7):2991-3002. PubMed ID: 38443648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study.
    Du-Thanh A; Merlet S; Maillard H; Bernard P; Joly P; Estève E; Richard MA; Pauwels C; Ingen-Housz-Oro S; Guillot B; Dereure O
    Br J Dermatol; 2011 Dec; 165(6):1337-43. PubMed ID: 21777222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for bullous pemphigoid: An updated systematic review of randomized clinical trials.
    Asilian A; Safaei H; Iraji F; Fatemi Naeini F; Faghihi G; Mokhtari F
    Med J Islam Repub Iran; 2021; 35():111. PubMed ID: 34956957
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score.
    Holtsche MM; Goletz S; van Beek N; Zillikens D; Benoit S; Harman K; Walton S; English J; Sticherling M; Chapman A; Levell NJ; Groves R; Williams HC; König IR; Schmidt E;
    Br J Dermatol; 2018 Oct; 179(4):918-924. PubMed ID: 29607480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy of bullous pemphigoid with mycophenolate mofetil: old drug, new use.
    Ratnam KV
    Singapore Med J; 2001 Oct; 42(10):482-4. PubMed ID: 11874153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term oral prednisolone exposure in primary care for bullous pemphigoid: population-based study.
    Persson MS; Harman KE; Thomas KS; Chalmers JR; Vinogradova Y; Langan SM; Hippisley-Cox J; Gran S
    Br J Gen Pract; 2021 Dec; 71(713):e904-e911. PubMed ID: 34607796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.
    Schmidt E; Obe K; Bröcker EB; Zillikens D
    Arch Dermatol; 2000 Feb; 136(2):174-8. PubMed ID: 10677092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study.
    Bratton DJ; Nunn AJ; Wojnarowska F; Kirtschig G; Sandell A; Williams HC
    Trials; 2012 Apr; 13():50. PubMed ID: 22540678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Nomacopan for Treatment of Bullous Pemphigoid: A Phase 2a Nonrandomized Controlled Trial.
    Sadik CD; Rashid H; Hammers CM; Diercks GFH; Weidinger A; Beissert S; Schauer F; Fettiplace J; Thaçi D; Ngai Y; Nunn MA; Zillikens D; Horváth B
    JAMA Dermatol; 2022 Jun; 158(6):641-649. PubMed ID: 35507334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UK Dermatology Clinical Trials Network's STOP GAP trial (a multicentre trial of prednisolone versus ciclosporin for pyoderma gangrenosum): protocol for a randomised controlled trial.
    Craig FF; Thomas KS; Mitchell EJ; Williams HC; Norrie J; Mason JM; Ormerod AD;
    Trials; 2012 Apr; 13():51. PubMed ID: 22540770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of treatments for bullous pemphigoid.
    Khumalo NP; Murrell DF; Wojnarowska F; Kirtschig G
    Arch Dermatol; 2002 Mar; 138(3):385-9. PubMed ID: 11902990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.